Replies to post #371135 on Innovation Pharmaceuticals Inc (IPIX)

[TradingPro]

As I have said before the ph2 results hit when the ABSSSI market suddenly chilled after the Cubist and Durata buyouts. Big BP started to question the ROI of the ABSSSI market. And the FDA crazy PhIII requirements was too costly for a BP to risk $$$, at that point in time.

[LIVED]

That's the explanation for B-OM and B-UC too, right?

starting, in 2022, a planned Phase 3 study of Brilacidin in Oral Mucositis is also in progress.

Once Brilacidin takes care of the most important stuff, happening in the world, then it's back to the regular stuff.

Damn, I love this "Gold Standard of CEO's and worth every penny".

[Empiricst1]

Thanks, for pointing that out. Pulled it yesterday, not today. Not sure what the issue is. As I float around the various absssi sites I grow increasingly aware of the hug market involved. And what a good chance it was (is?) for CTIX/IPIX.